Metabotropic glutamate receptor-mediated synaptic plasticity in the basal ganglia

基底神经节代谢型谷氨酸受体介导的突触可塑性

基本信息

  • 批准号:
    7909971
  • 负责人:
  • 金额:
    $ 2.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-01 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The basal ganglia play a critical role in controlling voluntary movement and motor learning. Disruption of basal ganglia function causes devastating movement disorders such as Parkinson's disease (PD). In order to discover novel treatments for disorders such as PD, intense effort has been focused on understanding transmission in the basal ganglia in both normal and pathological states (DeLong and Wichmann, 2007). Metabotropic glutamate receptors (mGluRs) are G protein-coupled receptors (GPCRs) that are widely expressed throughout the basal ganglia and modulate synaptic transmission at every major synapse within the basal ganglia motor circuit (Conn et al., 2005). Understanding the function of mGluRs in the basal ganglia in normal and disease states has led to identification of several mGluR subtypes that may provide promising targets for pharmacological treatment of PD. We are particularly interested in the role of group II mGluRs (mGluR2 and mGluR3) at the synapse between the subthalamic nucleus (STN) and the substantia nigra pars reticulata (SNr). The STN-SNr synapse is an excitatory synapse that plays a key role in regulating information output from the basal ganglia and is overactive in PD patients. Group II mGluRs regulate both acute and long- term depression (LTD) of excitatory transmission at the STN-SNr synapse (Bradley et al. 2000; Wittmann et al. 2002). For the proposed studies, I will use whole-cell electrophysiological techniques to measure excitatory postsynaptic currents from GABAergic SNr neurons in acute brain slices. First, I will use subtype-selective pharmacological tools that we have recently developed and mGluR2 and -3 knockout mice to determine which group II mGluR subtype(s) mediates acute and long-term effects of group II mGluR agonists on excitatory transmission. In addition, I will characterize the synaptic events involved in the induction of LTD in order to gain an increased understanding of the mechanisms underlying this novel form of synaptic plasticity. Finally, I will test the effect of dopamine depletion in order to understand how mGluR function might be altered in pathological states such as PD. Understanding how dopamine modulates mGluR function is important for the therapeutic potential of drugs targeting mGluRs for treating PD, as well as how changes in mGluR function may contribute to the pathogenesis of PD symptoms. PUBLIC HEALTH RELEVANCE: Studies of the functions of metabotropic glutamate receptors in the basal ganglia may lead to an increased understanding of the changes in basal ganglia function that contribute to the motor symptoms of Parkinson's disease. The results of these studies may also lead to improved treatments for managing the devastating symptoms of Parkinson's disease, which could increase the quality of life for many patients.
描述(由申请人提供):基底神经节在控制自愿运动和运动学习中起着至关重要的作用。基底神经节功能的破坏会导致诸如帕金森氏病(PD)等毁灭性运动障碍。为了发现针对PD等疾病的新疗法,强烈的努力集中在理解正常和病理状态的基底神经节的传播上(Delong和Wichmann,2007年)。代谢性谷氨酸受体(mglurs)是G蛋白偶联受体(GPCR),在整个基底神经节中广泛表达,并在基底神经节运动电路中的每个主要突触中调节突触传播(Conn等,2005,2005)。了解MGLUR在正常和疾病状态下基底神经节中的功能已导致鉴定出几种MGlur亚型,这些亚型可能为PD的药理治疗提供了有希望的靶标。我们对II组MGLURS(MGLUR2和MGLUR3)在亚丘脑下核(STN)和黑质Nigra pars niticulata(SNR)之间的作用特别感兴趣。 STN-SNR突触是一种兴奋性突触,在调节基底神经节的信息输出中起关键作用,并且在PD患者中过度活跃。 II组mglurs调节STN-SNR突触兴奋性传播的急性和长期抑郁(LTD)(Bradley等,2000; Wittmann等,2002)。对于拟议的研究,我将使用全细胞电生理技术来测量急性脑切片中GABA能SNR神经元的兴奋性突触后电流。首先,我将使用我们最近开发的亚型选择性药理学工具以及MGLUR2和-3基因敲除小鼠来确定哪种II组MGlur亚型介导了II组MGLUR激动剂对兴奋性传播的急性和长期影响。此外,我还将表征LTD诱导涉及的突触事件,以增强人们对这种新型突触可塑性形式的机制的了解。最后,我将测试多巴胺耗竭的作用,以了解如何在PD等病理状态中改变MGLUR功能。了解多巴胺如何调节MGLUR功能对于针对MGLURS治疗PD的药物的治疗潜力以及MGLUR功能的变化如何有助于PD症状的发病机理。 公共卫生相关性:对基底神经节中代谢剂谷氨酸受体功能的功能的研究可能会导致人们对基底神经节功能变化的了解,从而导致帕金森氏病的运动症状。这些研究的结果还可能导致治疗治疗帕金森氏病的毁灭性症状的治疗方法,这可能会增加许多患者的生活质量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kari Johnson其他文献

Kari Johnson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kari Johnson', 18)}}的其他基金

Thalamostriatal circuit contributions to behavioral inflexibility following adolescent ethanol exposure
青少年乙醇暴露后丘脑纹状体回路对行为僵化的影响
  • 批准号:
    10354795
  • 财政年份:
    2022
  • 资助金额:
    $ 2.57万
  • 项目类别:
Thalamostriatal circuit contributions to behavioral inflexibility following adolescent ethanol exposure
青少年乙醇暴露后丘脑纹状体回路对行为僵化的影响
  • 批准号:
    10579844
  • 财政年份:
    2022
  • 资助金额:
    $ 2.57万
  • 项目类别:
Presynaptic modulation of corticostriatal transmission following chronic ethanol exposure
慢性乙醇暴露后皮质纹状体传递的突触前调节
  • 批准号:
    10020296
  • 财政年份:
    2017
  • 资助金额:
    $ 2.57万
  • 项目类别:
Presynaptic modulation of corticostriatal transmission following chronic ethanol exposure
慢性乙醇暴露后皮质纹状体传递的突触前调节
  • 批准号:
    10241461
  • 财政年份:
    2017
  • 资助金额:
    $ 2.57万
  • 项目类别:
Metabotropic glutamate receptor-mediated synaptic plasticity in the basal ganglia
基底神经节代谢型谷氨酸受体介导的突触可塑性
  • 批准号:
    8258278
  • 财政年份:
    2010
  • 资助金额:
    $ 2.57万
  • 项目类别:
Metabotropic glutamate receptor-mediated synaptic plasticity in the basal ganglia
基底神经节代谢型谷氨酸受体介导的突触可塑性
  • 批准号:
    8097569
  • 财政年份:
    2010
  • 资助金额:
    $ 2.57万
  • 项目类别:

相似国自然基金

内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
  • 批准号:
    32300565
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Adrb2激动剂在改善呼吸机相关性膈肌功能障碍中的作用与机制研究
  • 批准号:
    82372196
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
  • 批准号:
    82303819
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
  • 批准号:
    82304340
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
  • 批准号:
    82304600
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Preclinical validation of mGlu2 PAMs in alcohol use disorder
mGlu2 PAM 在酒精使用障碍中的临床前验证
  • 批准号:
    10815668
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
Multi-scale functional connectivity in preclinical models of Parkinson's disease
帕金森病临床前模型的多尺度功能连接
  • 批准号:
    10334884
  • 财政年份:
    2022
  • 资助金额:
    $ 2.57万
  • 项目类别:
Mechanisms of Low-Dose Ketamine Treatment for Parkinson's Disease
小剂量氯胺酮治疗帕金森病的机制
  • 批准号:
    10437941
  • 财政年份:
    2021
  • 资助金额:
    $ 2.57万
  • 项目类别:
Central cholinergic presbyvestibulopathy network changes and imbalance in Parkinson's disease and older persons
帕金森病和老年人中枢性胆碱能性老年前庭病网络的变化和失衡
  • 批准号:
    10273747
  • 财政年份:
    2021
  • 资助金额:
    $ 2.57万
  • 项目类别:
Mechanisms of Low-Dose Ketamine Treatment for Parkinson's Disease
小剂量氯胺酮治疗帕金森病的机制
  • 批准号:
    10654668
  • 财政年份:
    2021
  • 资助金额:
    $ 2.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了